Testing effectiveness (Phase 2)Looking for participantsNCT06668571
What this trial is testing
Intravenous Ketamine for Treatment-Resistant Depression
Who this might be right for
Depressive Disorder, Treatment-ResistantTreatment Resistant Depression (TRD)
Mayo Clinic 30